Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: Evidence from a Canadian population-based cohort study

Population Health Metrics

Volumn 15, Issue 1, 2017, Pages

  Withrow, Diana R ^a   Pole, Jason D ^b   Nishri, E Diane ^c   Tjepkema, Michael ^d   Marrett, Loraine D ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PEDIATRIC ONCOLOGY GROUP OF ONTARIO   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d STATISTICS CANADA   (Canada)

Author keywords

Epidemiologic methods; Health status disparities; Indian, north American; Minority health; Neoplasms; Survival analysis

Indexed keywords

ADULT; CANCER; CAUSE OF DEATH; EPIDEMIOLOGY; ETHNICITY; HEALTH MONITORING; HEALTH STATUS; MINORITY GROUP; SOCIOECONOMIC STATUS; SURVIVAL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADIAN; CANCER MORTALITY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL ANALYSIS; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC DIFFERENCE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE SURVIVAL ANALYSIS; STOMACH CANCER; SURVIVAL ANALYSIS; SURVIVAL RATE; UTERINE CERVIX CANCER; ANCESTRY GROUP; CANADA; CAUSE OF DEATH; COMPARATIVE STUDY; DEMOGRAPHY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH DISPARITY; LIFE TABLE; MORTALITY; NEOPLASM; SOCIAL CLASS; SOCIOECONOMICS;

CANADA;

ADULT; AGED; CANADA; CAUSE OF DEATH; CENSUSES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASMS; RESIDENCE CHARACTERISTICS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 85021681276     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/s12963-017-0142-4     Document Type: Article

References (32)

1. Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15(1):186-215.
2. Dickman PW, Lambert PC, Coviello E, Rutherford MJ. Estimating net survival in population-based cancer studies. Int J Cancer. 2013;133(2):519-21.
3. Dickman PW, Adami H-O. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103-17.
4. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39(2):598-610.
5. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet Elsevier. 2011;377(9760):127-38.
6. Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-56.
7. Rachet B, Coleman MP. Commentary: estimating cancer survival-which is the right approach? Int J Epidemiol. 2010;39(2):dyq053-612.
8. Lambert P. STPM2: Stata module to estimate flexible parametric survival models. Statistical Software Components. Boston College Department of Economics; 2010. https://ideas.repec.org/c/boc/bocode/s457128.html.
9. Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Ins. 2010;102(20):1584-98.
10. Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. JNCI. 2010;102(20):1584-98.
11. Dickman PW, Auvinen A, Voutilainen ET, Hakulinen T. Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. J Epidemiol Community Health. 1998;52(11):727-34.
12. Skyrud KD, Bray F, Møller B. A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. Int J Cancer. 2014;135(1):196-203.
13. Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in surveillance, Epidemiology and end results (SEER) programme breast cancer patients. Stat Methods Med Res. 2001;10(5):339-52.
14. Wilkins R, Tjepkema M, Mustard C, Choinière R. The Canadian census mortality follow-up study, 1991 through 2001. Health Rep. 2008;19(3):25-43.
15. Peters PA, Tjepkema M, Wilkins R, Finès P, Crouse DL, Chan PCW, et al. Data resource profile: 1991 Canadian census cohort. Int J Epidemiol. 2013;42(5):dyt147-326.
16. Statistics Canada. Aboriginal identity population, by province and territory (2006 Census) [Internet]. statcan.gc.ca. Ottawa. Available from: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo60a-eng.htm. Accessed 30 Sept 2009.
17. Royston P, Lambert PC. Flexible Parametric Survival Analysis Using Stata. College Station: Stata Press; 2011.
18. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40(15):2307-16.
19. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer Elsevier. 2004;40(16):2494-501.
20. Withrow DR, Racey CS, Jamal S. A critical review of methods for assessing cancer survival disparities in indigenous population. Ann Epidemiol Elsevier. 2016;26(8):579-91.
21. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, et al. Global surveillance of cancer survival 1995-2009. Lancet. 2014;24:1-34.
22. Surveillance Epidemiology End Results Program. SEER Cause of Death Recode 1950+ (4/15/2002). seer.cancer.gov. Rockville; 2002. Available from: http://seer.cancer.gov/codrecode/1950+_d04152002/index.html.
23. Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence screening pilot study. Ann Oncol. 1998;9:1297-300.
24. McGregor M, Boivin J, McLean RG, Hanley JA. Screening for prostate cancer: estimating the magnitude of overdetection. CMAJ. 1998;159(11):1368-72.
25. Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer. Med Care. 2007;8:1-6.
26. Brenner H. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clin Oncol. 2004 8;23(3):441-7.
27. Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol Oxford University Press. 2013;178(3):339-49.
28. Sheppard AJ, Chiarelli AM, Marrett LD, Mirea L, Nishri ED, Trudeau ME. Detection of later stage breast cancer in first Nations women in Ontario. Canada Can J Pub Health. 2010;1:101-5.
29. Dignam JJ, Huang L, Ries L, Reichman M, Mariotto A, Feuer E. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts. Cancer. 2009 15;115(22):5272-83.
30. Berry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gøtzsche PC, et al. Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol. 2009;1:27(4).
31. Perme MP, Estève J, Rachet B. Analysing population-based cancer survival - settling the controversies. BMC Cancer BioMed Central. 2016;16(1):933.
32. Samphier ML, Robertson C, Bloor MJ. A possible artefactual component in specific cause mortality gradients. Social class variations in the clinical accuracy of death certificates. J Epidemiol Community Health. 1988;42(2):138-43.